Synapmed Announces Growing Prominence of Adverse Event Signal Detection Platform
NEW YORK, June 20, 2023 /PRNewswire/ — AstaLynx Global is pleased to announce the growing prominence of its proprietary signal detection and management system, ADRium-Signals™. Over the last 12 months, ADRium-Signals has replaced two of the top leading legacy signal detection systems at several midsize pharmaceutical companies. ADRium Signals has been selected by these companies for assessment […]